|
HGSNAT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.636800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.715800E-01 |
| Normal-vs-Stage2 |
5.925600E-01 |
| Normal-vs-Stage3 |
2.843800E-01 |
| Normal-vs-Stage4 |
4.055800E-01 |
| Stage1-vs-Stage2 |
2.881000E-01 |
| Stage1-vs-Stage3 |
5.769800E-02 |
| Stage1-vs-Stage4 |
1.334240E-01 |
| Stage2-vs-Stage3 |
7.453200E-01 |
| Stage2-vs-Stage4 |
8.536600E-01 |
| Stage3-vs-Stage4 |
8.808200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.295400E-01 |
| Normal-vs-AfricanAmerican |
8.386000E-01 |
| Normal-vs-Asian |
8.315200E-01 |
| Caucasian-vs-AfricanAmerican |
5.556400E-01 |
| Caucasian-vs-Asian |
9.716600E-01 |
| AfricanAmerican-vs-Asian |
7.985800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.466000E-01 |
| Normal-vs-Female |
4.267600E-01 |
| Male-vs-Female |
2.498400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.223200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.079600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.646600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.141600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.695600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.545580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.886400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.062600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.346300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.340200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.277000E-03 |
| Normal-vs-Grade 2 |
3.079200E-01 |
| Normal-vs-Grade 3 |
1.357560E-01 |
| Normal-vs-Grade 4 |
2.415200E-01 |
| Grade 1-vs-Grade 2 |
6.103800E-02 |
| Grade 1-vs-Grade 3 |
5.030100E-04 |
| Grade 1-vs-Grade 4 |
8.042100E-03 |
| Grade 2-vs-Grade 3 |
1.461400E-03 |
| Grade 2-vs-Grade 4 |
3.043900E-02 |
| Grade 3-vs-Grade 4 |
9.219000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.283000E-01 |
| Normal-vs-ccB subtype |
8.695400E-01 |
| ccA subtype-vs-ccB subtype |
8.692000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.754200E-01 |
| Normal-vs-N1 |
8.517400E-01 |
| N0-vs-N1 |
7.283800E-01 |
|
|
